I agree with ImQE regarding branding this as an ethical investment. Reading their annual reports, it seems that their number one priority is to make people's life better by innovating medical products, this will require a lot of moola initially. It's almost as if being profitable is secondary.
Where's The Report?, page-28
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.76 | $13.70 | $355.0K | 25.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 988 | $14.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.99 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |